Abstract
Compartmental modeling of indocyanine green (ICG) pharmacokinetics, as measured by near infrared (NIR) techniques, has the potential to provide diagnostic information for tumor differentiation. In this paper, we present three different compartmental models to model the pharmacokinetics of ICG in cancerous tumors. We introduce a systematic and robust approach to model and analyze ICG pharmacokinetics based on the extended Kalman filtering (EKF) framework. The proposed EKF framework effectively models multiple-compartment and multiple-measurement systems in the presence of measurement noise and uncertainties in model dynamics. It provides simultaneous estimation of pharmacokinetic parameters and ICG concentrations in each compartment. Moreover, the recursive nature of the Kalman filter estimator potentially allows real-time monitoring of time varying pharmacokinetic rates and concentration changes in different compartments. Additionally, we introduce an information theoretic criteria for the best compartmental model order selection, and residual analysis for the statistical validation of the estimates. We tested our approach using the ICG concentration data acquired from four Fischer rats carrying adenocarcinoma tumor cells. Our study indicates that, in addition to the pharmacokinetic rates, the EKF model may provide parameters that may be useful for tumor differentiation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.